Source: Eur Respir J, 54 (2) 1802221; 10.1183/13993003.02221-2018



Rating:

Share or cite this content

Citations should be made in the following way:
Kathryn Gracie, Martyn P.T. Kennedy, Georgina Esterbrook, Graham Smith, Parry Blaxill, Ali T. Ameri, Kirsty I.A. Rodger, Jonathan M. Robson, Elankumaran Paramasivam, Rehan Naseer, Peter Smith, Deborah A.B. Ellames, Bana Hawramy, Matthew E.J. Callister. The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening. Eur Respir J, 54 (2) 1802221; 10.1183/13993003.02221-2018

Member's Comments

No comment yet.

Related content which might interest you: Proportion of incident lung cancers that would have been eligible for a lung cancer screening program in Australia Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 The burden of paracancer diagnoses from patients attending a rapid access lung cancer clinic Source: Eur Respir J 2004; 24: Suppl. 48, 297s Year: 2004 Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT) Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021 Management of outpatients referred to a lung cancer diagnostic clinic Source: Eur Respir J 2007; 30: Suppl. 51, 435s Year: 2007 Evaluating the outcomes of patients with haemoptysis referred to two rapid-access lung cancer clinics in the UK Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Some characteristics of patients with lung cancer elected for palliative treatment Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 The efficacy of COPD detection by using a community-based annual screening program for lung cancer Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012 Prevalence of COPD in a lung cancer screening programme with low dose CT scan Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 The effects of chest physiotherapy applications in patients diagnosed with lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 653s Year: 2007 Audit of primary care referral guidelines for patients with suspected lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 63s Year: 2001 Weekly administration of gemcitabine in outpatient clinic for the patients with recurrent non-small cell lung cancer after pulmonary resection Source: Eur Respir J 2006; 28: Suppl. 50, 781s Year: 2006 Audit of process of care of elderly patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 The delays due to patient‘s and doctors‘ in non- small cell lung cancer patients Source: Annual Congress 2003 - Lung cancer management and prognosis Year: 2003 Analysis of advanced lung cancer patients diagnosed following emergency admission Source: Eur Respir J 2015; 45: 1098-1107 Year: 2015 The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Appropriateness of referrals to a fast track lung cancer clinic in the UK and effect on patient outcome Source: Eur Respir J 2007; 30: Suppl. 51, 432s Year: 2007 Resectable proportion of lung cancers in an unselected population Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015